The National Institutes of Health, Office of Personnel Management recently released new salary levels for the Executive Pay Scale.

Effective January 1, 2023, the salary cap for Executive Level II is $212,100.

You are encouraged to submit an abstract to highlight your research!

Click to Submit an Abstract!

Please encourage students to attend this workshop to learn more about writing conference abstracts.

The presentation will be offered in person as well as via Zoom.

Registration to attend in person closes Friday, February 3, 2023.

Pizza will be provided.

February 7, 2023 | 2-3PM Via Zoom

Presented by Brent Seeders, REDCap Liaison

CCTS Biomedical Informatics Core

For this training you should: NEVER USED REDCap

Contact Brent Seeders before this class to get a REDCap account

Class Objectives: 

• Never logged in/Log in 
• Orientation to REDCap/Navigation Bar
• Basic Features & Functions
• User Rights
• Reports
• Create a survey

Free 30-minute webinar January 31, 2023, at 2 pm (ET) to learn more about what’s to come for 2023: 

• Funding opportunities for comparative clinical effectiveness research (CER), dissemination and implementation research, and engagement projects  
• PCORnet, the National Patient-Centered Clinical Research Network®, a resource for conducting health research 
• Ways to share your experience and make your voice heard 

JCOIN is part of NIH's Helping to End Addiction Long-term (HEAL) integrated set of research initiatives, designed to provide scientific solutions to the opioid crisis. One of NIH's HEAL initiatives focuses on optimizing effective treatment effects for justice involved individuals. 

JCOIN Rapid Innovation Grants (J-RIG)

The JCOIN CTC administers the JCOIN Rapid Innovation Grant (J-RIG) program, which is a rapid funding mechanism to support small research grants to study newly emerging policies, practices, or interventions that address prevention and treatment of addiction among justice-involved populations.

J-RIG welcomes both applicants who work in research environments and those who do not work in research environments but could benefit from funding to study local initiatives, policy changes, or practice improvement efforts. J-RIG projects also are appropriate for developmental pilots, feasibility studies, or other research broadly defined as foundational work for further research and practice.

The J-RIG call for proposals will be released up to three (3) times per year. Funding will be provided for up to 24-months and may not exceed $100,000 and $110,000 in total costs.

Cycle 8: Proposals due February 15, 2023, by 11:59pm ET.

HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center

(U24 Clinical Trial Not Allowed) RFA-NS-22-021

The goal of this funding opportunity announcement is to support a Human Pain-associated Genes & Cells Data Coordination and Integration Center (DCIC) as part of the NIH HEAL Initiative’s Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain).The DCIC will curate, harmonize, and integrate comprehensive -omics and cellular function datasets generated by companion U19 Centers for Discovery and Functional Evaluation of Human Pain-associated Genes & Cells, which include the characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain signal transduction, transmission and processing.

The Human Pain-associated Genes & Cells DCIC will lead efforts to establish spatial and semantic standards for managing heterogeneous human pain-associated data types and information, collect and register multimodal human pain-associated data to common neural tissue coordinate systems, and establish a web-accessible information system that can be widely used throughout the research community. See attached pdf for more information.

HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed)

RFA-NS-22-018

The purpose of this funding opportunity announcement is to support research that uses human tissue or cells to generate comprehensive datasets for the discovery and characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain transduction, transmission, and processing. This FOA will support concerted multidisciplinary team science efforts that apply large-scale high-throughput approaches on tissues involved in human pain processing as part of the NIH HEAL Initiative’s Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain). U19 Centers will operate as a cooperative network to promote collaboration and coordination of research activities. U19 Centers will also coordinate with the U24 HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center that will curate, harmonize, and integrate datasets generated by this U19 research program. See attached pdf for more information.

Upcoming Receipt Date for these RFAs: March 9, 2023

For more information, PRECISION Human Pain program contacts:

D.P. Mohapatra, PhD ([email protected])  

Julia L. Bachman, PhD ([email protected]) 

Agency: National Institute of Allergy and Infectious Diseases (NIAID)

Description: This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.

Announcement Number:PAR-23-084

Closing Date: May 15, 2023; September 13, 2023

January 16, 2024; May 13, 2024; September 13, 2024

January 13, 2025; May 13, 2025; September 15, 2025

January 13, 2026

Agency: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Description: The purpose of this NIDDK Funding Opportunity Announcement (FOA) is to support pilot and feasibility trials to test pragmatic interventions that include screening for adverse social determinants of health (SDoH) and referring or providing resource service linkages for social services within the healthcare setting for individuals living with type 1 diabetes.

The pilot trials will determine

1. Feasibility of screening for social risks and implementing referral service linkages (e.g., connecting persons in need to appropriate transportation, housing, food, etc. resources) within the context of a healthcare encounter, and
2. Preliminary signals of the intervention’s impact on both the social risk(s) and type 1 diabetes (T1D) specific outcomes such as glycemic control.

The overarching goal of this FOA is to stimulate collaborations between healthcare systems, community-based organizations, and social service entities for testing and advancing effective interventions which integrate social care and medical care to reduce health disparities in T1D.

Announcement Number: RFA-DK-22-028

Closing Date: July 20, 2023 and February 29, 2024

Issued by: National Library of Medicine (NLM)

Purpose: The National Library of Medicine is issuing this Notice to highlight its interest in receiving grant applications focused on research that aims to reduce or mitigate gaps and errors in health data sets.

Notice Number: NOT-LM-23-001

Release Date: January 20, 2023

First Available Due Date: February 05, 2023

Expiration Date: January 08, 2026

Related Announcements

PAR-23-034 - NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)

PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

PA-20-185 - Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Description: The National Institute on Drug Abuse (NIDA) seeks collaborative research by multi-disciplinary teams to address critical issues of neuroscience, genetics, behavior, prevention, treatment, epidemiology, etiology, medications development, health services, HIV/AIDS and co-occurring opportunistic infections (e.g., viral hepatitis C, tuberculosis, sexually transmitted infections) and associated consequences in people who use or misuse substances or have a substance use disorder, or other research areas relevant to substance use, misuse, or use disorders.

Announcement Number: PAR-23-064

Closing Date: May 25, 2023

Issued by: National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers. Office of Research on Women's Health (ORWH)

Purpose: The National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), and Office of Research on Women’s Health (ORWH) are issuing this Notice of Special Interest (NOSI) to outline priorities for research in crisis response services. Research is sought that is conducted in real-world settings, where a wide range of clinical presentations, psychosocial factors, age-related (e.g., youth; adult; older adult), geographic (rural/remote settings), cultural considerations, and health disparities influence the types of care that are provided. Studies are encouraged that address the continuum of crisis service systems, as well as applications that address crisis services for children and under-resourced populations.

Related Announcements

NOT-MH-22-110 - Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services (RESCINDED) 

PAR-21-129 – Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01)

PAR-21-130 – Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)

PAR-21-131– Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 -Clinical Trial Required)

PAR-21-316 – Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)

PAR-22-082 - Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)

PAR-21-291 – Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required)

PAR-21-292 – Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)

PA-20-183 – Research Project Grant (Parent R01 Clinical Trial Required)

PA-20-185 – Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PA-21-110 – Pilot and feasibility studies in preparation for substance use prevention trials (R34 – Clinical Trial Optional)

PA-21-180 – Pilot health services and economic research on the treatment of drug, alcohol, and tobacco use disorders (R34 – Clinical Trial Optional)

PA-20-194 – NIH exploratory/developmental research grant program (Parent R21 Clinical Trial Required)

PA-20-195 – NIH exploratory/developmental research grant program (Parent R21 Clinical Trial Not Allowed)

Notice Number: NOT-MH-23-140

Release Date: January 18, 2023 

First Available Due Date: February 05, 2023

Expiration Date: May 08, 2025